Local Application of Autologous Bone Marrow Cells for Treatment of Chronic Diabetic Ulcers

Heidelberg University40 enrolled

Overview

Bone marrow cells were previously shown to enhance wound healing in experimental diabetes. In this pilot study, patients with chronic diabetic ulcers not healing under conventional therapy, will be treated with local application of autologous bone marrow cells.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Diabetic Foot Diabetes Complications

Interventions

Application of autologous bone marrowPROCEDURE

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Diabetes mellitus * chronic non-healing foot ulcers (\>4weeks) Exclusion Criteria: * Charcot foot * Non-diabetic ulcers * Ulcers healing under conventional therapy * Sepsis * Hematologic disorders * Pregnancy * Acute inflammatory disorders * Chemotherapy

Locations (1)

Medizinische Klinik 1, Universitätsklinikum Heidelberg

Heidelberg, Germany

RECRUITING

Outcomes

Primary Outcomes

Safety and Feasibility

Healing velocity

Central Contacts

Per Humpert, MD

CONTACT

+49 6221 56 per.humpert@med.uni-heidelberg.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.